Jake Bauer

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Ben Hohl, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jake Bauer:

Company Role Class Num Shares Value Price $ Report Date Ownership
Immunovant, Inc. Director Common Stock 25,016 $367,234 $14.68 01 May 2025 Direct
BridgeBio Oncology Therapeutics, Inc. Director Stock Option (Right to Buy) 138,193 26 Aug 2025 Direct
Immunovant, Inc. Director Stock Option (Right to Buy) 35,234 01 May 2025 Direct
Enliven Therapeutics, Inc. Director Stock Option (right to buy) 17,126 12 Feb 2026 Direct

Insider Reports Filed by Jake Bauer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELVN Enliven Therapeutics, Inc. 12 Feb 2026 1 $0 4 Director 17 Feb 2026, 19:56
HLXB BridgeBio Oncology Therapeutics, Inc. 26 Aug 2025 1 $0 4 Director 28 Aug 2025, 16:41
HLXB BridgeBio Oncology Therapeutics, Inc. 11 Aug 2025 0 $0 3 Director 18 Aug 2025, 17:14
IMVT Immunovant, Inc. 01 May 2025 2 $0 4 Director 05 May 2025, 19:30
IMVT Immunovant, Inc. 18 Apr 2025 0 $0 3 Director 28 Apr 2025, 17:02
ELVN Enliven Therapeutics, Inc. 06 Feb 2025 1 $0 4 Director 10 Feb 2025, 17:34
ELVN Enliven Therapeutics, Inc. 13 Feb 2024 1 $0 4/A Director 20 Feb 2024, 19:26
ELVN Enliven Therapeutics, Inc. 13 Feb 2024 1 $0 4 Director 15 Feb 2024, 20:44
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 1 $0 4 Director 06 Apr 2023, 20:16
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 2 $0 4 Director 27 Feb 2023, 20:51
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 0 $0 3 Director 27 Feb 2023, 20:44
/report/000114036121024134-bauer-jake-2021-07-12 ARYA Sciences Acquisition Corp V 12 Jul 2021 0 $0 3 Director 12 Jul 2021, 19:54